SCHEMBL7919905

SCHEMBL7919905

NCc1ccccc1-c1ccc(C(=O)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.66
FOLH1 Q04609 2/20 0.56
KMT2A Q03164 1/20 0.47
RXRA P19793 2/20 0.46
RXRB P28702 1/20 0.46
RXRG P48443 1/20 0.46
SRD5A2 P31213 2/20 0.46
MAP4K4 O95819 1/20 0.45
TSHR P16473 3/20 0.45
DAO P14920 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
F10 P00742 2/20 0.44
EGFR P00533 1/20 0.43
RARB P10826 1/20 0.43
RARG P13631 1/20 0.43
CYP2C19 P33261 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9513400 0.85 FOLH1 (0.59) FOLH1KMT2ARXRARXRBRXRG
Bicarbonate SCHEMBL27817695 0.85 DPP4 (0.83) DPP4FOLH1KMT2ACYP2C19
SCHEMBL28055856 0.84 DPP4 (0.58) DPP4FOLH1KMT2AF10CYP2C19
SCHEMBL2040404 0.84 FOLH1 (0.58) FOLH1KMT2ARXRARXRBRXRG
SCHEMBL6310180 0.82 FOLH1 (0.56) FOLH1KMT2ARXRARXRBRXRG
SCHEMBL28697910 0.82 FOLH1 (0.60) FOLH1KMT2ARXRARXRBRXRG
SCHEMBL18624971 0.81 FOLH1 (0.50) FOLH1RXRARXRBSRD5A2MAP4K4
SCHEMBL8368461 0.81 FOLH1 (0.61) DPP4FOLH1RXRARXRB
SCHEMBL21803820 0.81 TTR (0.51) DPP4FOLH1KMT2ASRD5A2TSHR
SCHEMBL2981250 0.81 DPP4 (0.91) DPP4FOLH1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106029057-B Oral formulations of pyrrolidine derivatives 奥布赛瓦股份公司 2019-09-03 CN disclosed
CN-109928905-A As oxytocins/pitressin V1a receptor antagonist pyrrolidin derivatives 奥布赛瓦股份公司 2019-06-25 CN disclosed
CN-109748836-A As oxytocins/pitressin V1a receptor antagonist pyrrolidin derivatives 奥布赛瓦股份公司 2019-05-14 CN disclosed
CN-107674011-A Pyrrolidin derivatives as oxytocins/pitressin V1a receptor antagonists 奥布赛瓦股份公司 2018-02-09 CN disclosed
CN-106795110-A Crystalline (3Z, 5S) -5- (hydroxymethyl) -1- [ (2 '-methyl-1, 1' -biphenyl-4-yl) carbonyl ] pyrrolidin-3-one O-methyloxime useful in methods of treating disorders associated with OT-R activity 奥布赛瓦股份公司 2017-05-31 CN disclosed
CN-106029057-A Oral formulations of pyrrolidine derivatives 奥布赛瓦股份公司 2016-10-12 CN disclosed
CN-105531259-A Pyrrolidine derivatives as oxytocin/vasopressin V1a receptor antagonists ObsEva SA 2016-04-27 CN disclosed
CN-101970420-B Oxadiazole derivatives MERCK SERONO SA 2014-09-24 CN disclosed
CN-101970420-A Oxadiazole derivatives MERCK SERONO SA 2011-02-09 CN disclosed
US-6228985-B1 COMPOUNDS THAT INHIBIT INTERACTION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR WITH UROKINASE-TYPE PLASMINOGEN RECEPTOR; ANTITUMOR AGENTS; ANTIMETASTASIS AGENTS; ANTIARTHRITIC AGENTS FOR RHEUMATOID ARTHRITIS SCHERING CORPORATION 2001-05-08 US disclosed